November 3, 2010
Two Billion Dollar Cancer Deal Sealed by US Drug Distributor
Cancer specialist US Oncology will be bought by McKesson, a leading US drug distributor, in a stock-and-debt deal worth about 2.16 billion dollars, the companies said.
Cancer specialist US Oncology will be bought by McKesson, a leading US drug distributor, in a stock-and-debt deal worth about 2.16 billion dollars, the companies said.
Fortis Healthcare has announced that it has completed the redevelopment work at Chennai’s Malar hospital which it had acquired two years ago. Fortis
Pfizer, US pharmaceutical giant, has bought 40 percent of Brazilian drug company Teuto for a whopping 238 million dollars.
The purchase could lead
Data from a previously completed and announced Phase 3 randomized, placebo-controlled clinical trial of Probuphine were unveiled by Titan Pharmaceuticals, Inc.
Pfizer, the world’s largest drug maker, said Tuesday it will buy King Pharmaceuticals for 3.6 billion dollars in a bid to boost its position in the pain-relief market.
The Wockhardt hospital group has signed a deal with National Union of Seafarers of India (NUSI) for their hospital property in Goa. The area located
A newspaper report has revealed that British drug maker GlaxoSmithKline (GSK) is to make thousands of chemical compounds that have the potential to cure malaria available for research.
Mariam Diallo is finally hopeful of finding proper treatment for her child suffering from sickle cell disease, after losing six family members to the terrible condition.
Surya Pharmaceuticals has announced that it has signed a deal with US Company Crocs, under which it will market the latter’s medical footwear range in India.
A partial retrial against Pfizer in the case of an Arkansas woman who got breast cancer after taking hormone replacement therapy has been allowed by the US Supreme Court.